Silvio Danese, Janusz Rudziński, Wolfgang Brandt, Jean-Louis Dupas, Laurent Peyrin-Biroulet, et al.. Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study.
Gut, BMJ Publishing Group, 2015, 64 (2), pp.243 - 249.
⟨10.1136/gutjnl-2014-308004⟩.
⟨hal-01685640⟩